Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Kyverna links CAR-T to autoimmune improvements in small trial
Kyverna saw deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101.
Nick Paul Taylor
Oct 29, 2025 10:00am
Galapagos to wind down cell therapy unit, threatening 365 jobs
Oct 21, 2025 9:30am
Novo ends all cell therapy R&D, lets go of staff
Oct 10, 2025 3:30pm
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
Novo calls off $598M Heartseed collab, citing 'strategic reviews'
Sep 30, 2025 1:55pm
